Effects of estradiol–drospirenone hormone treatment on carotid artery intima-media thickness and vertigo/dizziness in postmenopausal women

被引:0
作者
Hakan Coksuer
Mustafa Koplay
Fatih Oghan
Cengiz Coksuer
Nadi Keskin
Olcay Ozveren
机构
[1] Dumlupınar University,Department of Obstetrics and Gynecology, Faculty of Medicine, School of Medicine
[2] Dumlupinar University,Department of Radiology, School of Medicine
[3] Dumlupinar University,Department of Otorhinolaryngology, School of Medicine
[4] Dumlupinar University,Department of Cardiology, School of Medicine
[5] Cizre State Hospital,undefined
来源
Archives of Gynecology and Obstetrics | 2011年 / 283卷
关键词
Cardiovascular disease; Carotid intima-media thickness; Drospirenone; Menopause; Vertigo/dizziness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1045 / 1051
页数:6
相关论文
共 146 条
[1]  
Van der Schouw Y(1996)Age at menopause as a risk factor for cardiovascular mortality Lancet 347 714-718
[2]  
Van der Graaf Y(1996)Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women Clin Endocrinol 45 435-441
[3]  
Steyerberg EW(1995)Oestrogen replacement therapy and progression of intimal-thickness in the carotid arteries of postmenopausal women Am J Epidemiol 142 1011-1019
[4]  
Eijkemans MJC(1993)Isolated systolic hypertension and vessel wall thickness of the carotid artery: The Rotterdam Elderly Study Arterioscler Thromb 13 64-69
[5]  
Banga JD(2006)Conjugated equine estrogens and coronary heart disease Arch Intern Med 166 357-365
[6]  
McCrohon JA(2003)Pharmacology of estradiol valerate/dienogest Climacteric 6 17-23
[7]  
Adams MR(2000)A comparative investigation of contraceptive reliability Eur J Contracept Reprod Health Care 5 124-134
[8]  
McCredie RJ(2005)Effects of drospirenone/17-β estradiol on blood pressure and potassium balance in hypertensive postmenopausal women Am J Hypertens 18 797-804
[9]  
Espeland MA(2000)Essential hypertension. Part I. definition and etiology Circulation 101 329-335
[10]  
Applegate W(1992)Assessment of the risk of postmenopausal osteoporosis using clinical risk factors Clin Endocrinol (Oxf) 36 225-258